NCT02479464View on ClinicalTrials.gov

Clinical Impact of the Antidepressant Pharmacogenomic Algorithm in an Outpatient Therapy-based Clinical Setting

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

September 30, 2010

Study Completion Date

August 31, 2014

Conditions
Major Depressive Disorder
Interventions
GENETIC

Genotyping results

Genotyping results provided in Phase II

Sponsors

Lead Sponsor

Mayo Clinic

Collaborators (1)

AssureRx Health, Inc.
All Listed Sponsors
collaborator

AssureRx Health, Inc.

INDUSTRY

lead

Mayo Clinic

OTHER